Assignee
ONYX PHARMA INC
US·52 granted patents·6 pending applications·1,934 citations·filing 1993–2022
Top patents by PatentIndex Score
58 records- 0197US5846945ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1995·Granted Dec 8, 1998·235 cites·5 claims
- 0297US5677178ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1996·Granted Oct 14, 1997·227 cites·29 claims
- 0395US6723316B2Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Apr 20, 2004·71 cites·10 claims
- 0494US6225060B1Baculovirus expression system and method for high throughput expression of genetic materialONYX PHARMA INC·Filed 1999·Granted May 1, 2001·218 cites·22 claims
- 0594US5801029ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1995·Granted Sep 1, 1998·126 cites·23 claims
- 0694US5525490AReverse two-hybrid methodONYX PHARMA INC·Filed 1994·Granted Jun 11, 1996·201 cites·12 claims
- 0792US7001596B1Oncolytic adenovirusONYX PHARMA INC·Filed 2000·Granted Feb 21, 2006·45 cites·11 claims
- 0891US6428960B1Selection method for producing recombinant baculovirusONYX PHARMA INC·Filed 2000·Granted Aug 6, 2002·127 cites·15 claims
- 0990US5856181ACytopathic viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1997·Granted Jan 5, 1999·71 cites·4 claims
- 1088US7307071B2RAF-MEK-ERK pathway inhibitors to treat cancerONYX PHARMA INC·Filed 2002·Granted Dec 11, 2007·31 cites·8 claims
- 1184US2022267372A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2022·Application pending·0 cites
- 1283US6635244B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2001·Granted Oct 21, 2003·11 cites·7 claims
- 1382US5539085ABcl-2 and R-ras complexONYX PHARMA INC·Filed 1993·Granted Jul 23, 1996·62 cites·6 claims
- 1481US7396679B2Oncolytic adenovirusONYX PHARMA INC·Filed 2002·Granted Jul 8, 2008·9 cites·16 claims
- 1581US7078030B2Oncolytic adenovirusONYX PHARMA INC·Filed 2003·Granted Jul 18, 2006·21 cites·9 claims
- 1680US5597719AInteraction of RAF-1 and 14-3-3 proteinsONYX PHARMA INC·Filed 1994·Granted Jan 28, 1997·105 cites·6 claims
- 1779US7442534B2Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteinsONYX PHARMA INC·Filed 2002·Granted Oct 28, 2008·5 cites·14 claims
- 1879US6013464AHuman PAK65ONYX PHARMA INC·Filed 1997·Granted Jan 11, 2000·34 cites·17 claims
- 1979US5518911AHuman PAK65ONYX PHARMA INC·Filed 1995·Granted May 21, 1996·32 cites·12 claims
- 2076US2020325172A1Compounds for proteasome enzyme inhibitionONYX PHARMA INC·Filed 2020·Application pending·0 cites
- 2174US6379665B1Phospholipase D polypeptide and DNA sequencesONYX PHARMA INC·Filed 2000·Granted Apr 30, 2002·6 cites·11 claims
- 2274US5698445AHuman PAK65ONYX PHARMA INC·Filed 1996·Granted Dec 16, 1997·25 cites·15 claims
- 2372US7994294B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2006·Granted Aug 9, 2011·1 cites·8 claims
- 2469US6569655B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2001·Granted May 27, 2003·2 cites·6 claims
- 2568US7785887B2Adenovirus E1B-55K single amino acid mutants and methods of useONYX PHARMA INC·Filed 2003·Granted Aug 31, 2010·1 cites·15 claims
- 2668US6296845B1Selective killing and diagnosis of p53+ neoplastic cellsONYX PHARMA INC·Filed 1998·Granted Oct 2, 2001·31 cites·12 claims
- 2768US5756669AP53-binding polypeptides and polynucleotides encoding sameONYX PHARMA INC·Filed 1995·Granted May 26, 1998·36 cites·15 claims
- 2866US7556955B2Nucleic acids encoding Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Jul 7, 2009·0 cites·17 claims
- 2965US12076363B2Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancersONYX PHARMA INC·Filed 2021·Granted Sep 3, 2024·0 cites·16 claims
- 3065US6017763AG-beta-gamma regulated phosphatidylinositol-3' kinaseONYX PHARMA INC·Filed 1999·Granted Jan 25, 2000·14 cites·25 claims
- 3164US6500653B1Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteinsONYX PHARMA INC·Filed 1999·Granted Dec 31, 2002·12 cites·13 claims
- 3264US5948643AModulators of BRCA1 activityONYX PHARMA INC·Filed 1997·Granted Sep 7, 1999·18 cites·7 claims
- 3363US7141404B2Candida kefyr cytosine deaminaseONYX PHARMA INC·Filed 2003·Granted Nov 28, 2006·0 cites·8 claims
- 3463US6762284B1Nucleotide sequences that encode phosphatidylinositol-3′ kinase associated proteins and uses thereofONYX PHARMA INC·Filed 2000·Granted Jul 13, 2004·2 cites·3 claims
- 3563US5705342AInteraction of BCL-2 and R-RASONYX PHARMA INC·Filed 1995·Granted Jan 6, 1998·15 cites·10 claims
- 3662US6660259B2Herpes simplex virus for treating unwanted hyperproliferative cell growthONYX PHARMA INC·Filed 2000·Granted Dec 9, 2003·1 cites·15 claims
- 3762US6133243ALiposomal-viral DNA complexes for treating diseaseONYX PHARMA INC·Filed 1996·Granted Oct 17, 2000·17 cites·10 claims
- 3861US7148002B2Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 2003·Granted Dec 12, 2006·0 cites·14 claims
- 3961US5698428AHuman PAK65ONYX PHARMA INC·Filed 1997·Granted Dec 16, 1997·12 cites·37 claims
- 4060US6133419ANucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereofONYX PHARMA INC·Filed 1997·Granted Oct 17, 2000·16 cites·7 claims
- 4159US7414113B2Antibody that specifically binds to Candida kefyr Cytosine deaminaseONYX PHARMA INC·Filed 2006·Granted Aug 19, 2008·0 cites·8 claims
- 4258US5605825AHuman PAK65ONYX PHARMA INC·Filed 1995·Granted Feb 25, 1997·10 cites·29 claims
- 4357US6080578ACytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasiaONYX PHARMA INC·Filed 1997·Granted Jun 27, 2000·24 cites·10 claims
- 4457US2021338766A1Methods of treating multiple myelomaONYX PHARMA INC·Filed 2021·Application pending·0 cites
- 4555US7829329B2Adenoviral vectors for treating diseaseONYX PHARMA INC·Filed 2002·Granted Nov 9, 2010·0 cites·8 claims
- 4655US6764674B1Adenovirus E1B shuttle vectorsONYX PHARMA INC·Filed 1999·Granted Jul 20, 2004·11 cites·14 claims
- 4754US6238881B1Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPaseONYX PHARMA INC·Filed 1997·Granted May 29, 2001·12 cites·13 claims
- 4849US5876711AMethods and compositions for determining the tumor suppressor status of cellsONYX PHARMA INC·Filed 1996·Granted Mar 2, 1999·10 cites·7 claims
- 4948US6511825B1Cell signaling polypeptides and nucleic acidsONYX PHARMA INC·Filed 1999·Granted Jan 28, 2003·11 cites·11 claims
- 5048US2005003507A1Method for purifying virusONYX PHARMA INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →